Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-10-08
1979-11-13
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2601125R, 424 12, A61K 4300, G01N 3316
Patent
active
041743857
ABSTRACT:
It has now been determined that cancer cells have a specific surface protein existing as a glycoprotein which functions to stimulate specific cell-mediated immune response in the host directed toward the specific cancer. The following disclosure includes the method of identification of the specific cell surface protein and procedures utilizing the protein, or preferably the active peptide in testing for specific cancers and immunization. Having identified the specific cell surface protein for a cancer, the n-terminal tridecapeptide or the active portion of the peptide may be synthesized and utilized in testing and immunization. Further, the specific cell surface protein and active peptide for ductal carcinoma (brest cancer) is identified herein.
REFERENCES:
patent: 4041023 (1977-08-01), Felix et al.
Alpern Robert
Ellis Jerry Michael
Fealk Sheldon A.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Method of identification of surface proteins of cancer cells, cl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of identification of surface proteins of cancer cells, cl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of identification of surface proteins of cancer cells, cl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2272102